About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
Unlock the market timeline & signal feed
10,594 signals in the last 90 days.
The order this company entered each market — oldest to newest
Go beyond anti-cancer therapy in oncology PGx
Which oncology PGx targets matter most?
Sign up to see the full signal feed
How Thermo Fisher Scientific's international expansion compares to its competitors
Thermo Fisher ScientificYouBars show relative size across the companies compared.
5 metrics| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 Thermo Fisher ScientificYou | 62 | 0 | -23% | 10.5k | 50 |
Scaling fast — 6,148 roles opened in the last 90 days, up 102% vs the prior period. Engineering-led and concentrated in United States.
Bulgaria · 3w ago
Localization Engineer, EMEA
Greenville, NC · last mo.
Validation Manager
Tucson, AZ · 3d ago
Clinical Research Coord I
54 technologies detected across the stack.
570 active campaigns across 234 markets.
Ended
Active
Ended31 mentions in the last 90 days.
GMO's 13F portfolio increased from $39B to $44B, with Microsoft leading. Significant builds in Thermo Fisher, KLA, and NVIDIA, while reducing Lam Research, Alphabet, and U.S. Bancorp positions.
Amplidea unveiled FluoroSplit™ RVP Plus at Next Generation Dx Summit 2026 in Washington D.C., featuring upgraded multiplex respiratory virus diagnostics including SARS-CoV-2 detection using proprietary TISP technology.
Goldman Sachs reports that portfolios commonly held by major hedge funds and mutual funds achieved 29% returns this year, with increased focus on financial stocks including Mastercard, Visa, and Capital One.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Thermo Fisher Scientific's business, markets, and growth signals.
“We reach accounts the week they land in-market — not the quarter after.”
Book a walkthrough of the movement map with our team.
Pubrio turns expansion signals across 200+ markets into one live graph, so revenue teams see which companies are entering new markets, and act on the timing.
© 2026 Pubrio. All rights reserved.
